
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.